We recently published a list of the 13 Most Undervalued Blue Chip Stocks To Buy According To Analysts. In this article, we ...
Merck (MRK) stock is in focus as a Phase 3 trial for its cancer drug Keytruda in colorectal cancer patients did not meet ...
Ethereum, or 1 ETH, traded at $2,636.77 as of 8 a.m. ET. The highest intraday price the cryptocurrency reached in the past ...
Merck's Phase 3 KEYFORM-007 study on the combination of favezelimab and pembrolizumab in MSS mCRC patients did not improve ...
Merck said on Wednesday its therapy did not meet the main goal of a late-stage trial evaluating it in patients with a type of ...
Merck & Co Inc. (MRK) on Wednesday said its Phase 3 KEYFORM-007 study evaluating the company's drug candidate favezelimab in ...
Merck (MRK) announced the Japanese Ministry of Health, Labor and Welfare has approved new indications for KEYTRUDA or pembrolizumab, ...
Shares of Merck & Co. Inc. MRK dropped 0.58% to $114.96 Tuesday, on what proved to be an all-around positive trading session ...
An FDA advisory panel on Bristol Myers Squibb Opdivo and Merck Keytruda will examine if PD-L1 tumor expression should limit ...
Merck & Co.'s stock fell 0.5% premarket Wednesday, after the drug company said a late-stage trial of its blockbuster cancer drug Keytruda in combination with favezelimab failed to meet the main goal ...
Pastor Corey Brooks, founder of Project H.O.O.D., said migrants are adding to the city of Chicago's crime issue. Brooks went ...
Listen to this article Financial services provider Merchants Capital Tuesday announced more than $59 million in financing for ...